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Abstract 
 
microRNAs (miRNAs) are the small non-protein-coding RNA, Regulate target gene expression 
via transcriptional degradation or translational repression. In this study our aim was to 
investigate the role of miR-429 in metastasis process in fibrosarcoma and its possible mode of 
regulation. Microarray data analysis for fibrosarcoma, is trying to screen out the probable 
miRNAs and genes responsible for metastasis. After gating a novel pair of gene and miRNA, 
Experimental validation of selected gene and miRNA expression was carried out through qRT-
PCR in fibrosarcoma cell line HT1080, as compare to normal fibroblast cell line WI-38. The role 
of miR-429 in metastasis was further accessed via over-expression of the miRNA in HT1080 and 
carrying out during in-vitro metastasis detection assay like cell migration, cell proliferation 
assays, By using different assay we found that miR-429 expression is decreased in Fibrosarcoma 
where it might be acting as tumor suppressor in cellular model, Where it prevents tumor 
development by negatively inhibiting oncogene KIAA0101 that induce cell proliferation, cell 
migration. But  Over expression of miR-429  inhibits  the cell proliferation and cell migration 
which might be  helping  in  metastasis  and ultimately contributing to lethality  of  
Fibrosarcoma. 
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Introduction 
           Sarcomas are a heterogeneous group of mesenchymal tumors with specific molecular 
characteristics, and the current classification is based on their tissue of origin and its histological 
appearance. They are one of the most serious cancer types in the world. They are a very rare 
group of the mesenchymal tumor, derived from connective tissue such as -blood, bone, cartilage, 
dense fibrous tissue, muscle tissue and adipose tissue [Coley WB. II Ann Surg, 1891].  It is also 
known as mesenchymal neoplasm. They differ from carcinomas because of their origin, as 
sarcomas origin from connective tissue, and carcinoma from epithelial tissue. 
                 Sarcomas are involved in the abnormal growth of connective tissue that includes five 
major steps for sarcoma development: initiation, promotion, malignant conversion, progression, 
and metastasis.  And Metastasis is the process in which malignant tumor cell leaves the primary 
site and migrates to a distance site via circulatory system and lymphatic system and establishes a 
secondary site. Metastatic development is a very complex process and requires multiple 
individual steps to establish a tumor at a secondary site.  
                 The metastatic process involves a change at the molecular level that disrupts and 
modifies the tumor cell-extracellular matrix interactions and cell–cell interaction. There is a 
movement of malignant cell from the primary tumor to distant organs through the lymphatic or 
hematogenous circulatory system.  It involves six major steps: local invasion, intravasation, 
transport through circulation, extravagation, formation of micro-metastasis colonization 
[Stoletov K, Kato H at al, 2001]. About 10% of deaths in patients with cancer occur due to the 
primary tumor, but 90% of death is due to the metastasis  of cancer cells [Coley WB. II Ann 
Surg 1998]. 
                Metastasis it is a process in which the malignant tumor cell leaves the primary site and 
migrate to a distance site via circulatory system and lymphatic system and establish a secondary 
site. Metastasis in sarcoma is the combined interaction of both tumor inducers, which promote 
tumor development and tumor suppressors, which inhibit tumor growth [Calin et al. 2004]. There 
are many  of molecules which are involved in metastasis like mRNAs, non-coding RNAs like 
miRNAs, piRNAs,miRNA is one of them. The identification of these molecules and their 
mechanism of involvement are under extensive investigation.  Although several of these 
molecules, which act as either tumor suppressors or oncogenes, have been identified in model 
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animal genomes, and human their precise role in metastasis is not well understood. Metastasis is 
well understood extensively studied in cancers of epithelial origin but is not clearly understood in 
cancers of mesenchymal origin (sarcoma). 
                         There are many molecule involves in metastatic process but miRNAis one of 
them. These are small non-protein coding RNAs, being extensively studied and may provide new 
insight into cancer research. miRNA are the important regulatory molecules in plants and 
animals. Their function is to regulate the gene expression in a variety of manners such as- 
translational repression, transcriptional degradation or mRNA deadenylation.  From literature 
study  about 50% of miRNA genes are located in cancer-associated genomic regions and also 
know as in fragile sites [Calin et al., 2004] suggesting that miRNAs may play a more important 
role in metastasis.  
                          Our aim was validation of expression of the miR-429 and its target gene 
KIAA0101 obtained from microarray analysis of myxoidfibrosarcoma tissues by using 
fibrosarcoma cell line HT1080 and establish the role of the miRNA in metastasis.   
                           To detect the expression of selected miR -429 and KIAA0101 (qRT-PCR) was 
carried out  in fibrosarcoma cell lines (HT-1080) as a test sample and normal fibroblast cell 
(WT-38). We found that miR-429 was down-regulated and KIAA0101 is over-expressed. To 
further establish their role in metastasis different assays were performed such as MTT to check 
cell viability, proliferation and migration assay.  
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Review of literature 
Sarcomas are a rare heterogeneous family of malignant neoplasm and they share presumptive 
origins from the mesoderm or endoderm. However most of the origin of sarcomas remains 
unclear [ MackalL CL, Meltzer PS, Helman LJ (2002)]. 
Sarcomas are divided into two types: based on the origin 
1.Soft tissue sarcoma- These arise from connective tissues such as muscles, fat, nerves, and 
fibrous tissue blood vessels . About 80% of sarcomas are occur in soft tissues.[ World Health 
Origination] on the basis of occurrence ,soft tissue sarcoma occupies a 23rd position among all 
cancer.Based on the origin of cancer there are many types of soft tissue sarcoma. The cells of  
sarcoma look different from each other under a microscope. 
Table1. types of sarcoma based on their origin: 
Types of sarcoma  Cells forming tumor 
Angiosarcoma lymphatic vessel or Blood  
Chondrosarcoma Cartilage cells 
Gastrointestinal stromal tumor tract Gastrointestinal tract 
Fibrosarcoma Fibrous tissue 
Leiomyosarcoma Gastrointestinal tract 
Liposarcoma Fat tissue 
Malignant peripheral nerve sheath tumor Nerve and Spinal Cord 
Fibrosarcoma: 
It is a mesenchymal   tumor that origin from the fibrous tissue, Fibrosarcomas are a form of solid 
tumors and are different grades according to the degrees of differentiation: low grade that is 
differentiated, intermediate grade and high grade (anaplastic). Depending on this differentiation, 
the tumour cells may resemble mature spindle-shaped fibroblasts that secrete collagen. High 
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grade fibrosarcomas mostly shows metastasis that is they have the capacity to enter into local 
tissues thus spreading tumors to different body parts. Majority of deaths in fibrosarcoma is 
mainly due to metastasis which is poorly diagnosed or poorly understood. 
2.Osteosarcoma:  It is also known  as osseous sarcoma that origin from  bone. They are much 
less common In comparison with benign bone tumor and secondary cancer,. It occupies 27th 
position among all cancer on the basis of occurrence.   
            
 
                             Figure: 1 Types of cancer 
Metastasis is the process by which malignant tumor cells leaves the primary site and migrate to a 
distance site within the body and establish a secondary tumor . [Chambers AF, Groom AC, 
MacDonald IC (2002)]. This is the major reason of treatment failure of sarcoma and death of 
sarcoma patients. It is a very complex process that requires multiple individual steps to establish 
a tumor at a secondary site.  This process involves a change at the molecular level that modifies 
and disrupts the cell-extracellular matrix interactions and tumor cell–cell interaction. These 
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molecular changes due to cadherins  and integrins  signaling through cell adhesion molecules 
(CAMs) , tissue remodeling through the action of proteinases enzyme like metalloproteinases 
(MMPs), plasmin, growth factors, and chemokines. These molecules mediate cell processes such 
as proliferation, migration, invasion, survival and apoptosis [Nguye DX, Bos PD, Massague J 
(2009)].These mechanisms describe the metastatic cascade in sarcoma that is largely unknown, 
and which may differ significantly from that of carcinoma, in which there is a preliminary 
knowledge. 
The spread of cancer cells to other parts of the body is depends on: 
 Original location of the cancer 
 The type of cancer 
 The stage of cancer 
 
 Metastatic Process 
 
 
Intravasation
Extravasation
Formation of micrometastasis
Colonization
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Figure: 2 Different stages of metastasis- 1) Local invasion 2) Intravasation 3) Transport through 
circulation 4) Extravagation 5-6) Formation of micro-metastasis 6) Colonization. 
Metastatic sites 
The site where the primary tumor will migrate to and estabilish a colony at distance site or 
secondary malignant tumor is called the site of metastasis. Metastatic site is organ specific. For 
organ selectivity, 2 theories are there- Mechanistic theory: According to it the pattern of blood 
flow determines organ site. Seed and soil theory (Fokas et al. 2007): According to it spreading 
will occur to that site where there is fertile environment so that compatible tumor cells can grow 
(Nguyen et al. 2009). 
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Common site of metastasis are: 
 
The spread of tumor cells can occur either through lymphatic or blood vasculature leading to 
metastases to distant organ. Though metastasis is well understood in cancers of epithelial origin 
(carcinoma), but it is not clearly understood in cancers of mesenchymal origin (sarcoma). 
 
Micro RNAs (miRNA) 
                      MicroRNAs (miRNAs) are the small non-coding RNA, length is about 18–22 
nucleotides . They regulate the gene expression in a variety of manners; this includes 
transcriptional degradation, translational repression, and deadenylation. They binding to 
3′untranslated regions (UTR), and coding sequences or 5′UTR of target messenger RNAs 
(mRNAs) and regulate gene expression posttranscriptional. They are partially complementary to 
messenger RNA (mRNA) molecules, [ V. Ambros, Nature,2004].miRNAs regulate about 30% of  
protein-coding genome in human.[W. Filipowicz, S.N. Bhattacharyya, N. Sonenberg, Nat. Rev. 
Genet. 9 (2) (2008).] 
                        The first miRNA was discover in Caenorhabditis elegans , and the miRNA is lin-
4 ,in 1993 by [ Lee R. C. et al.]  Till now thousand of miRNAs have been identified in various 
Cancer type Main site of metastasis 
Bladder liver,  Bone,  lung 
Breast  brain, liver, lung 
Colorectal  lung, peritoneum, Liver, 
Kidney Adrenal gland,  brain, liver, lung 
Lung bone, Adrenal gland  brain, liver,  
Melanoma brain,liver, lung, Bone, skin/muscle 
Ovary lung, peritoneum, Liver, 
Pancreas Liver, lung, peritoneum 
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organisms by the help of computational prediction, sequencing and random cloning.  miRBase, is 
a data base from where we can retrieve sequence data, miRNA nomenclature,  annotation and 
target prediction information, and hosted by the Sanger Institute. 
miRNA biosynthesis 
miRNAs encode by genes which are much longer than the processed mature miRNA molecule. 
Most of miRNAs are present  in introns of their pre-mRNA host genes and they  share  a 
common regulatory elements, RNA polymerase II are involved in the transcription of miRNAs  [  
Lee Y. et al. EMBO J. 2004, ]. By the help of microprocessor complex, The pri-miRNAs are 
processed in the nucleus, which contain Drosha (RNase III enzyme) [Han, J. et al. Genes Dev. 
2004,] and Pasha/DGCR8 a double-stranded-RNA-binding protein, The pre-miRNAs are about 
70-nucleotides, and are folded into imperfect stem-loop structures. Then the pre-miRNAs are  
exported into the cytoplasm with the help of karyopherin exportin 5 (Exp5) and Ran-GTP 
complex [Yi, R. et al.Genes Dev. 2003]. Ran is essential for the RNA and proteins translocation 
through the nuclear pore complex [Moore, M. S. et al Nature 1993]. The Ran GTPase forms a 
nuclear heterotrimer with pre-miRNAswhen it  binds to Exp5, After generating of the pre-
miRNAs  in cytoplasm it finaly form a mature miRNA by undergo an additional processing step 
with the help of RNAse III enzyme Dicer , a mature RNA  is aproximately 22 nucleotides in 
length. Dicer initiatesto  formation the RNA-induced silencing complex (RISC). RISC is 
responsible for the gene silencing due to RNA interference and miRNA expression [ Hammond, 
S. M. Dicing and slicing: 2003]. 
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Figure:3  (1) miRNAs are transcribed by RNA polymerase II (pol II) into long pri-miRNA 
transcripts of variable size, which are recognized and cleaved in the nucleus by the RNase III 
enzyme Drosha, resulting in an hairpin precursor form called pre-miRNA. (2) This pre-miRNA 
is exported from the nucleus to the cytoplasm by exportin 5 and is further processed by another 
RNase enzyme called Dicer (3), which produces a transient 19–24 nucleotide duplex. Only one 
strand of the miRNA duplex (mature miRNA) is incorporated into a large protein complex called 
RISC (RNA induced silencing complex). (4) The mature miRNA leads RISC to cleave them 
RNA or induce translational repression depending on the degree of complementary sites between 
the miRNA and its target.  
miRNA targeting: 
miRNA regulate the gene expression via translational repression, transcriptional degradation and 
deadenylation. They binding to 3′untranslated regions (UTR), and coding sequences or 5′UTR of 
target messenger RNAs (mRNAs) and regulate gene expression posttranscriptional. They are 
partially complementary to mRNA molecules, [ V. Ambros, Nature,2004]. According to the 
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Watson and Crick pairing rule towards 5’ region of miRNA transcriptional repression miRNA 
helps in predicting miRNA target which indicate the specific targeting. One-third of the human 
gene follows the rule to maintain their pairing,  
KIAA0101 is a protein coding gene and also known as ݌ଵହ௉ி஺   PCNA-associated factor .which 
is located in chromosome no 15 in human. It is 15-kDa weight protein,and also know as 
proliferation cell nuclear antigen (PCNA)-associated protein and  p15PAF, L5, and OEATC-1. 
Their main function is to regulate the cell proliferation, cell cycle progression, DNA 
repair,migration. [Yu P,Huang B, Shen M, et al. 2001] 
Over expressed p15PAF, protein helps to protects cells from UV –light (which induced cell 
death) [ Warbrick E. A 2006].Developmental stages of p15PAF  protein expression is highly 
restricted in mouse embryos, [Petroziello J, Yamane A, Westendorf L, et al.2003] But it shows 
aberrant expression in various cancers, such as brain, breast, kidney, uterine cervix, esophageal  
hepatic, lung, and colon cancers.[ Mizutani K, Onda M, Asaka S, et al.2005]. Some of the 
clinical studies on p15PAF have supported  that it function as an oncogene and induce tumor 
progression [Guo M, Li J, Wan D, et al 2006]. There are also reports of it functioning as a tumor 
suppressor in hepatocellular carcinoma [Shanghai Medical College, Fudan University, Shanghai, 
China. guomingleicn]  
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Objectives 
 
 
Objective: 1  
 
Microarray analysis for obtaining differentially expressed genes and miRNAs in Fibrosarcoma. 
 
 
Objective: 2 
 
Generation of miRNA-mRNA interaction map and prediction of putative novel target pair 
involved in metastasis of fibrosarcoma  
 
Objective: 3  
 
Experimental validation of selected gene and miRNA expression through qRT-PCR  
 
 
Objective: 4 
 
To study of role of miRNA in metastasis of fibrosarcoma via different in vitro assays  
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TOTAL FLOWCHART OF EXPERIMENT 
 
                    Figure: 4 flow chart of experiment 
Gene expression data 
For gene expression analysis of mRNA and miRNA in order to study the differentially expressed 
genes/miRNA in control and diseased sample in fibrosarcoma expression data is taken from 
Gene Expression Omnibus (GEO) data base.  
From GEO data base we can retrieve sequencing, microarray, and next generation sequencing 
data.It supports MIAME submissions that collects and provides freely next generation 
sequencing data, microarray data and high throughput functional genomic data which is 
submitted by the scientific community. 
 For our analysis we had collect the sample, miRNA and  mRNA  expression data of the fat 
sample as a control and fibrosarcoma as a test sample.  
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PLATFORMS taken- 
 
Expression Data GEO accession Title 
mRNA  GPL96 Affymetrix Human Genome U133A Array 
miRNA  GPL8179  Illumina Human v2 MicroRNA expression beadchip 
 
Samples taken: 
 
Expression Data GEO accession Title 
mRNA  GSE21122  
 
Whole-transcript expression data for soft-tissue sarcoma 
tumors and control normal fat specimens 
miRNA  GSE36982 MicroRNA profiling of primary high-grade soft tissue 
sarcomas and control normal fat 
 
2) Microarray analysis of  gene Expression Data: 
 
A) Gene expression analysis: 
 Gene expression analysis is done   By using Agilent’s GeneSpring GX 12.6 software. 
 All samples collected from GEO data base were consider for further analysis     
 (fibrosarcoma and normal control fat present in the GSE was taken for analysis.) 
 
Table 3. Total Number of samples taken for mRNA and miRNA expression analysis 
Gene expression data Name of sample No of samples 
mRNA Normal fat 9 
mRNA MFH:Myxofibrosarcoma 31 
miRNA Myxofibrosarcoma 8 
miRNA Normal fat 2 
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B) miRNA expression analysis:  
          miRNA expression analysis was done using GeneSpring, using a miRNA specific platform 
such as Illumina. For further analysis we consider  only those miRNAs which are  differentially 
expressed greater than 2 fold between the control and test samples .  
C) Analysis of Gene and miRNA list: 
          To finding a probable oncogene the gene ontology analysis was carried out, for the genes 
which are up-regulated using web based gene set analysis GO analysis (gene ontology). Genes 
with functions and probable role in metastasis was further focused on. 
1) Target interaction map through Magia2 Software: 
This study was carried out to display miRNA –Mrna interaction. In a given biological context. A 
set of gene is designed to detect consistent effects of microRNAs on the joint expression of 
multiple targets. In a single test, the association between microRNA expression and target gene 
set expression, and the contribution of the individual target genes in the association are 
determined. 
IN VITRO VALIDATION: 
A) Cell Line and Culture  
For in vitro cell culture Fibrosarcoma cell line HT-1080 was used which was collected 
from National Centre for Cell Science, Pune,    as a test sample.Normaly it is 
culture in DMEM (Dulbecco’s Modified Eagle’sMedium) growth media , which contain 
high L-glutamine supplemented with 10% fetal bovine serum, glucose and 1% penstrep 
antibiotic solution were used.  It was incubated in CO2 incubator, maintained at 5% CO2 
concentration and 100% humidity. According to logarithmic growth all experimental 
analysis was done with cells. The media contains a ph indicator, phenol red,  and the 
color of medium changes when the media is utilize by cells,it change from red to orange 
,finally to pale yellow because of change in pH.  
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 WI-38 was collect from Bose Institute Kolkata, as control sample.  
 
B) RNA ISOLATION: 
       RNA extraction from HT-1080 and WI-38 
 mRNA isolation: 
For mRNA isolation HIMEDA kit (HiPurATMTotal   RNA minipre Purification Kit) was 
used according to the manufacturer’s instructions.  
Procedure 
1) We had harvested a maximum of 1 × 107 cells and appropriate volume of RLT  buffer was 
added. 
2) 1 volume of 70% ethanol was added to the lysate, and mixed well by pipetting.  
3) 700μl of sample including any precipitation was transferred to an RNeasy mini spin column 
Placed in 2ml supplied collection tube. Then the lid was closed and centrifuged for 15 sec at 
≥8000xg.Then discarded the flow through. 
4) To RNeasy spin column 700μl of RW1 was added. Then the lid was closed and centrifuged  
for 15 sec at 8000xg.Then flow through was discarded. 
5) To RNeasy spin column 500μl of RW1 was added. Then the lid was closed and centrifug for 
15 sec at ≥ 8000xg.Then flow through was discarded. 
6) To RNeasy spin column 500μl of RW1 was added. Then the lid was closed and centrifuge for 
2 minute at ≥ 8000xg. 
7) In a new 1.5ml collection tube the RNeasy spin column was placed. 30-40μl RNase free water 
was added directly to spin column membrane. Then the lid was closed and centrifuged for 1 
minute at ≥ 8000xg in order to elute RNA. 
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8) If the expected RNA yield is more than 30μg, then the step-7 was repeated using another 30- 
50μl of RNase free water or using the elute from step-7.The collection tube were reused from 
Step-7. 
9) By using Eppendorf Nan Drop, the purity and yield of RNA was measured. It is a curette free 
spectrophotometer eliminating the need for other sample containment device and also allows for 
clean up in seconds. 1μl of the sample can be measured with this instrument with high accuracy 
and reproducibility. 1μl of sample was pipette onto the end of a fiber optic cable. A second 
fibrotic cable is then brought into contact with the liquid sample causing the liquid to bridge the 
gap between the fiber optic ends. A pulsed xenon flash lamp provides the light source and 
spectrometer utilizing a linear CCD array is used to analyze the light after passing through the 
sample.  
C) Micro RNA (miRNA) isolation: 
For miRNA isolation from HT1080 and WI-38 mirVanaTM Isolation kit from Ambion was used. 
1) Cells were collected after trypsinization. And then wash with PBS   and cells pellets were 
collected, then it was kept in ice for some minute. 
2) PBS was removed, 600 μl lysis or binding solution was added.   (If the cells are 100s in 
number -300 μl)If cells are 1000s -600 μl) 
3) Now the solution was vortex vigorously to make homogenous lysate. 
4) 1/10th (for 600/10=60 μl) of microRNA homogenate additions was added to cell, then mixed 
Well by vertaxing or inverting several times , then kept on ice for 10 minute. 
5) 1 volume of Acid phenol chloroform that is equal to lysate volume is added before addition of 
miRNA homogenate, then vortexed for 30 to 60 sec in order to mix then it was centrifuged for 5 
min at 10,000 g at room temperature to separate aqueous and organic phases. (After 
Centrifugation the interphase should be compact if it is not then centrifugation is repeated) 
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6) Aqueous phase is carefully removed without disturbing the lower phase and transferred into a 
new tube. 
7) 1.25 volume of room temperature 100% ethanol was added to aqueous phase. 
8) A filter cartridge was placed into one of the collection tubes, then it was mixed by pipetting 
then centrifuged for 15 sec at 10000 rpm, then flow through was discarded until all the lysate is 
through. 
9) 700μl of miRNA wash solution I was added to filter cartridge and then centrifuged for 5 to 10 
sec and then flow through was discarded. 
10) 500 μl of wash solution 2/3 centrifuged it for 5 to 10 sec. Again repeat it with 500 μl of wash 
solution 2/3. 
11) After discarding the flow through from last wash, the filter cartridge was replaced same in 
collection tube and assembly was undergo spinning for 1 min to remove residual fluid from 
12) Filter cartridge was transferred into a fresh collection tube .100μL of pre heated (95oC) 
elution buffer or nuclease free water was applied ,cap was closed and it undergo spinning for 20 
to 30 sec at maximum speed to remove microRNA. 
13)The elute was collected and stored at -20oC or below. 
 
D) cDNA SYNTHESIS 
 
 cDNA  Synthesis of mRNA  
Total RNA was reversely transcribed using an Invitrogen’s first-strand cDNA Synthesis Kit 
using oligo dT primer in a total volume of 20 μl. Before use as a template for PCR 
amplification the cDNAwas stored at −80°C. 
1) Each of the components were mixed and centrifuged briefly before use. 
2) For each reaction the following in a sterile 0.2 or 0.5 tube was combined. 
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Component Amount 
RNA (2ug) 4 μl 
10mM dNTP mix 1 μl 
Primer - oligo (dT) 1 μl 
DEPC treated water 4 μl 
            
3) The RNA/Primer mixture was incubated at 65°C for 5 minute and then placed on ice 
for atleast 1 minute. 
Component 1RXn 10RXn 
10X RT buffer 2 μl 20 μl 
25Mm Mgcl2 4 μl 40 μl 
0.1MDTT 2 μl 20 μl 
RNase out (400/μL)  μl 10 μl 
 
4) Following 2X reaction was prepared in a separation tube by adding each component in 
the indicated order. 
5) To each RNA/Primer from step 3, 9μl of 2X reaction mixture was added, mixed gently 
collected by a brief centrifuge. 
     6) It was incubated at 42°C for 2 minute. 
     7)1μl of superscript TM II RT was added to each tube. 
 8) It was incubated for 50 minute at 42oc. 
     9) The reaction was terminated at 70oc for 15 minute and then chilled on ice. 
10) By brief centrifugation the reaction was collected. To each tube 1 μl of RNase H was 
added and incubated at 37oc for 20 minute and then the reaction was used for PCR 
immediately. 
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 cDNA Synthesis of miRNA :For cDNA synthesis an invitrogen kit (NCodeTMVILOTM 
miRNA cDNA Synthesis kit was used.  
1) 100 to 1μg of optimal RNA was taken. 
            2) DNase I may be used to eliminate genomic cDNA contain. 
            3) Undiluted cDNA are to be used for qRT-PCR. 
 4) The following reaction volume may be scaled as needed upto 100μl .For single  
reaction, combine the following components in a tube on ice. For a multiple reactions a 
master mix is prepared without RNA. 
Component Amount 
5X reaction mix 4 μl 
10X superscript 2 μl 
Total RNA (1ug) 2.5 μl 
DEPC treated water 11.5 μl 
          
5) The tube was capped then gently vortexed to mix and centrifuge then briefly. 
6) The tube was then incubated at 37°C for 60 minute, terminated at 95°C for 5 minute 
and then hold the reaction at 4°C until use. 
QUANTATIVE RT-PCR ANALYSIS: 
It is used to amplify and simultaneously detect and quantify the targeted RNA molecule.  
         Two common methods are there for qRT-PCR: 
 Non-specific fluorescent dyes that is intercalate with any double-stranded DNA, such as 
SYBR green.  
 Sequence-specific DNA probes consisting of oligonucleotides that are labeled with 
a fluorescent reporter which permits detection only after hybridization of the probe with 
its complementary sequence to  (mRNA) and non-coding RNA in cells or tissues. 
 
We used SYBR green dye as a florescent dye. 
1) Procedure of mRNA qRT-PCR 
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 To perform PCR by using RNA as a  template, it must first have to transcribed  into 
cDNA by a reverse transcription reaction, in which cDNA is act as template for RT-
PCR with gene specific primers.  
Table  No 4. Primer name and sequence with length and its amplicon size 
 
Primer name Sequence Amplicon size 
 
ACTB F- F-CATGTACGTTGCTATCCAGGC 250 
 R- R-CTCCTTAATGTCACGCACGAT  
p15PAF F- F-ATGGTGCGGACTAAAGCAGAC 123 
 R- R-CCTCGATGAAACTGATGTCGAAT  
miR-429 F-CGGCGTAATACTGTCTGGTAAAACCGT  22  
 
In Eppendorf Master plex Real Time PCR, RT-PCR was carried out.  Beta actin (ACTB) was 
used as endogenous control. Primer concentration was normalized and gene specific forward and 
reverse primer pair was mixed. Each primer that is forward and reverse primer concentration in 
mixture was 3.5μl. 
a) Now the experiment was ready and the following PCR program was made on. A copy of 
the set up file was saved and all other PCR cycles were deleted. Threshold frequency was 
taken was 33%. The temperature cycle were taken as follows: 
Stages Temperature (oc) Time Cycle 
Stage 1 95 20 sec 1 
Stage 2 95 
55 
68 
15 sec 
15 sec 
20 sec 
40 
Stage 3 95 
60 
95 
15sec 
15sec 
15sec 
1 
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b) cDNA was diluted to 1:20 ratio concentration to use 20ng per reaction and then 
primer was added. 
              c) 10μl of a real time PCR reaction volume was made. 
        
Reagent 
 
 Amount 
 
SYBR Green Mix(2x) 
35μl 
cDNA stock(cDNA:dH2O[1:20])  
40 μl 
 
Primer pair mix(3.5μl each primer) 
 
7 μl 
                 
                d) In each optional tube as the following mixture was made follows. 
                e) With the help of in-built software , the RT-PCR result was anal 
               f) The tubes were removed from the machine, after PCR is finished. 
2) Procedure of miRNA qRT-PCR 
a) Undiluted cDNA was used for quantification. 
b) 10μl of a real time PCR reaction volume was made. 
In each optional tube as the following mixture was made follow 
 
Reagent Amount 
SYBR Green Mix(2x) 5 μl 
cDNA stock 2μl 
DEPC H2O 2.6 μl 
Forward primer 0.2 μl 
Reverse Primer 0.2 μl 
 
    c) With the help of in-built software, the RT-PCR result was analyzed. 
d) The tubes were removed from the machine, after PCR is finished. 
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C) miRNA Over expression: 
 miRNA over expression was done by transfection of miRNA mimic, obtained from Sigma. It 
contains artificial miRNA-like RNA fragments and mimics a natural double stranded miRNA 
molecule.  
miRNA mimic Transfaction. 
miRNA mimic and scramble at 40 nM concentration was transfected into HT-1080 Cell line 
using Lipofectamine 2000 Invitrogen, according to the manufacturer’s instructions. 
D) qRT-PCR of mimic treated gene 
 Same mRNA and miRNA isolation procedure is followed for mimic treated cell and non treated 
gene. 
E) Proliferation assay 
Cells were transfected with a miR-429 mimic using Lipofectamine 2000 (cat# 11668-027, 
Invitrogen) according to the manufacturer’s instructions. The cell proliferation assay was done 
with the 3- (4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction assays. 
Cells were seeded into 96-wells plates for MTT analysis. Twenty-four hours after cell 
transfections, 20 ߤL of MTT (5mg/mL) was added into each well and incubated for 4 hours. 
After that, the supernatant was discarded, and then 150 ߤL dimethyl sulfoxide was added to each 
well and oscillated for 10min to dissolve the precipitate. Finally, OD absorbance (at 570 nm) was 
measured using UV spectrophotometer at 24 hours, 48 hours, and 72 hours after transfection. 
The assay was performed three times in triplicates.  
D) Scratch assay or Wound healing assay 
The scratch assay allows studying cell migration and cell interactions.  
1. Seed the cells in multi-well plates and culture until confluent. Using a pipette tip make a 
straight scratch, simulating a wound.  
2. We had make a scratch keeping the pipette tip under an angle of around 30 degrees to 
keep the scratch width limited, and which is suitable for imaging of both wound edges . 
Scratch assay is suitable for studies on the effects of cell-cell interactions, cell-matrix interaction, 
on cell migration, mimic cell migration during wound healing. 
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Result 
1. mRNA Expression analysis : There are  1068 differentially expressed gene were obtain  
from miRNA expression analysis between Myxofibrosarcoma and the normal fat 
samples, out of these 558 gene are up regulated and 510 gene are down regulated. This 
Hierarchical clustering showed that relatedness among test and control sample. 
 
 
 
 
Fig 5: Hierarchical clustering of MFS and normal fat samples 
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2. microRNA Expression Analysis: 
There are 77 differentially expressed miRNAs were obtained between Myxofibrosarcoma 
and the fat samples. From these 51 miRNA were up-regulated and 27 miRNA wear 
down-regulated. 
 
  
 
                                           
Fig 6: Hierarchical clustering of differentially expressed miRNA. 
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3. Target interaction map analysis: 
The Target interaction map resulted shows that 36 genes targeted by the miR-429 and 4 gene 
target by miR-37. 
       
Figure: 7 Interaction map Analysis of mRNA and miRNAs involved in fibrosarcoma 
 
4. RNA hybrids:  
 This result shows that KIAA0101 form hybrid with hsa-miR-429 at position 22067 and Eight 
nucleotide pairing (8 mer)  and form a thermodynamically stable binding having  (Minimum free 
energy) Mfe -15.2kca/mol. Due to which we select miR-429-and  KIAA0101 as novel pair and 
responsible for metastasis in fibrosarcoma. 
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5) Quantative RT-PCR analysis: of 6 KIAA0101 Expression in HT1080 vs WI-38 
 
 
                   
 
Figure:9    P15 (PAF) Expression in HT1080 vs WI-38 
 
 The real time PCR shows that  Expression of p15(PAF) is 3.5 fold up regulate in HT-1080 as 
compaire to control sample WI-38. 
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6) Quantitative PCR data analysis of miRNA in HT1080 vs WI-38 
             
 
                         Figure :10 miRNA in HT1080 vs WI-38 
 
The real time PCR shows that  Expression of miR-429 is 3.25 down regulate in HT-1080 as 
compaire to control sample WI-38. 
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7) Quantative RT-PCR data analysis of miRNA expression after mimic treatment 
 
 
Figure 11: miRNA expression after mimic treatment 
Post mimic treatment the expression of miR-429 is 62 fold up regulated. This showed that the 
miRNA transfected was stably over expressed. 
8) qRT-PCR data analysis : KIAA0101 Expression post miRNA treatment 
                  
             Figure: 12 P15 (PAF) Expression post miRNA treatment 
After mimic treatment expression of mRNA is 3.2 fold down regulated. Over expression of 
miRNA suppress the expression of mRNA . 
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9) Proliferation assay  
 
                Figure: 13 cell viability at different time durition 
 
After transfect ion of miRNA mimic, cell viability is less in mimic treated cell. It indicate that 
mimic inhibits to proliferation of HT-1080 cell, whereas scramble doesn’t inhibit. At 0 hrs cell 
viability is same on both mimic treated and scramble treated is 0.2 at OD 570nm, but at 24hrs 
cell viability is 0.41 in mimic treated and 0.43 in scramble, At 48hrs and 72 hrs cells viability  or 
proliferation rate is more in scramble as compare to mimic treated miRNA.  
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Scratch assay 
                                                     Scramble Treated cell 
                   0 hrs                                            12 hrs                             24 hrs 
 
 
1) miR-429 mimic treated  
        0 hrs                                    12 hrs                                24 hrs 
 
Figure 14: scratch assay of mimic treated cell and scramble treated cell 
 
Scramble treated HT-1080 cells migrate first to fill up the scratch as compare to mimic treated 
HT-1080 cells. Mimic treated cells are inhibited by miRNA mimic due to which HT-1080 cell 
restrict to fill up the scratch. And conclude that miRNA mimic inhibit the migration, by acting a 
tumor suppressor. 
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Conclusion:  
 
miR-429 expression is decreased in Fibrosarcoma where it might be acting as tumor suppressor 
miRNA in cellular model, Where it prevents tumor development by negatively inhibiting 
oncogene KIAA0101 that induce cell proliferation, cell migration. Over expression of miR-429  
inhibits  the cell proliferation and cell migration which might be  helping  in  metastasis  and 
ultimately contributing to lethality  of  Fibrosarcoma. From the emerging evidence of our project 
miRNAs function tumor suppressors, and regulate mRNA expression. Transfection of miRNAs 
to regulate metastasis of fibrosarcoma , artificial miRNAs could be synthesized to down-regulate 
the function of miR-429   and prevent the formation of metastasis by inhibiting cell proliferation 
and cell migration. Thus, artificial miRNAs can be designed to block the expression of these 
tumor suppressor gene based on the complementary characteristics of miRNAs to their targeted 
mRNAs. From the evidence suggests that miRNAs play important roles in metastasis of 
fibrosarcoma. Some miRNAs may be directly involved in fibrosarcomsarcoma development by 
controlling cell differentiation and cell migration, while others may be involved in sarcoma by 
targeting sarcomas oncogenes and/or tumor suppressors. Understanding of the Function of 
miRNAs is providing the new way on the molecular basis of fibrosarcom, and new biomarkers 
for diagnoses and sarcomas therapy.  
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